3313 articles
David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patien...
Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person's relationships, physical health, and plans for the futur...
Mark McDonough, CEO of ChromaCode, a molecular diagnostics company, discusses how ChromaCode technology provides a cost-effective, rapid, and accurate...
Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare - the only pharmaceutical company solely focused on HIV, discusses...
Amy Meyer, Manager of Primate Experimentation Campaigns for People for the Ethical Treatment of Animals (PETA) discusses what is happening to animals in...
Scott Montgomery, CEO and Director of Advanced Health Intelligence (AHI), a technology company developing smartphone-based human scanning technology ...
Darrell Gray, MD, MPH, FACG, Chief Health Equity Officer at Elevance Health discusses how and why health equity should be authentically embedded and ref...
Danielle Zerr, MD, MPH, Medical Director of Infection Prevention at Seattle Children's discusses the expected severe shortage of infectious disease spec...
Michael Axt, Chief Member Empowerment Officer at Zelis, a company modernizing the healthcare financial experience, discusses recent research outlining c...
Paul Lammers, MD, MSc, President and Chief Executive Officer at Triumvira Immunologics discusses the company's work in the development of novel, targete...